20-HETE is associated with unfavorable outcomes in subarachnoid hemorrhage patients

Emerging evidence has suggested that patients experiencing aneurysmal subarachnoid hemorrhage (aSAH) develop vascular dysregulation as a potential contributor to poor outcomes. Preclinical studies have implicated the novel microvascular constrictor, 20-hydroxyeicosatetraenoic acid (20-HETE) in aSAH...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cereb Blood Flow Metab
Autors principals: Donnelly, Mark K, Crago, Elizabeth A, Conley, Yvette P, Balzer, Jeffery R, Ren, Dianxu, Ducruet, Andrew F, Kochanek, Patrick M, Sherwood, Paula R, Poloyac, Samuel M
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4640341/
https://ncbi.nlm.nih.gov/pubmed/25920956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jcbfm.2015.75
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars